Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: Very High
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
60,034
Total Claims
$2.7M
Drug Cost
684
Beneficiaries
$3,957
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+4%
Opioid rate vs peers
2.3% vs 2.2% avg
+180%
Cost per patient vs peers
$3,957 vs $1,411 avg
+8%
Brand preference vs peers
11.5% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.3%
Opioid Rate
1,394
Opioid Claims
$58K
Opioid Cost
8.2%
Long-Acting Rate
Brand vs Generic
Brand: 6,895 claims · $1.8M
Generic: 53,066 claims · $910K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,510 | $363K |
| Rifaximin | 139 | $156K |
| Empagliflozin | 206 | $92K |
| Deutetrabenazine | 13 | $73K |
| Dulaglutide | 103 | $65K |
| Rivaroxaban | 205 | $59K |
| Insulin Detemir | 150 | $57K |
| Valbenazine Tosylate | 14 | $56K |
| Fluticasone/Umeclidin/Vilanter | 88 | $55K |
| Brexpiprazole | 105 | $46K |
| Semaglutide | 38 | $36K |
| Linaclotide | 57 | $35K |
| Mirabegron | 160 | $30K |
| Insulin Aspart | 95 | $30K |
| Atorvastatin Calcium | 2,851 | $28K |
Prescribing Profile
Patient Profile
76
Avg Age
60%
Female
2.20
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About